Source-labeled articles connected to this topic.
Retatrutide documentation guide explaining what COAs can and cannot establish, identity versus purity testing, batch traceability, third-party laboratory records, and why vial appearance is not proof of identity.
Understand why peptide purity and identity are different questions and what HPLC, mass spectrometry, and related reports can show.
Updated source-labeled Retatrutide hub covering Phase 2 starting amounts and escalation, 24- and 48-week outcomes, Phase 2 versus Phase 3 designs, tolerability, heart rate, body composition, current development status, and documentation context.
A practical guide to third-party testing claims, laboratory independence, report verification, and documentation gaps.
Learn how to read peptide COA fields, separate identity from purity, check batch traceability, and spot missing documentation.